On-going monitoring: Lipid profile
On-going monitoring: Lipid profile
Two to three months after starting treatment with a statin, a repeat blood test for the lipid profile should be undertaken to assess response to therapy. For those people who do not achieve the required reduction in LDL-C/non-HDL-C, where possible, the statin dose should be optimised.
Additional or alternative options should be considered for those people who are unable to tolerate statins at all, or if the maximum or maximum tolerated dose of statin treatment is not to target.